Table 4 Changes in DNA methylation in human placenta following exposure to DEHP.
From: Prenatal DEHP exposure predicts neurological disorders via transgenerational epigenetics
TargetID | Δ Beta-value | Chromosome number | Position | P-value | Gene name | Distance from TSS | Annotation |
|---|---|---|---|---|---|---|---|
cg00445443 | − 0.1176 | 7 | 27,143,478 | 0.0286 | HOXA3 | 2330 | Intergenic |
cg02163322 | − 0.1034 | 4 | 1,017,759 | 0.0305 | FGFRL1 | 11,508 | Gene body |
cg02399469 | − 0.1298 | 19 | 57,631,118 | 0.0198 | USP29 | 390 | Promoters |
cg04481096 | − 0.1180 | 7 | 27,142,100 | 0.0459 | HOXA2 | 2128 | Gene body |
cg06568768 | − 0.2181 | 15 | 23,814,371 | 0.0492 | MKRN3 | 3551 | Gene body |
cg16636671 | 0.1537 | 3 | 147,126,403 | 0.0497 | ZIC1 | 748 | Promoters |
cg18092977 | − 0.1524 | 14 | 101,190,167 | 0.0145 | DLK1 | 3034 | Intergenic |
cg20414687 | − 0.1022 | 19 | 57,646,348 | 0.0304 | ZIM3 | 885 | Gene body |
cg21213388 | − 0.1312 | 9 | 138,387,515 | 0.0065 | C9orf116 | 489 | Intergenic |
cg23541304 | − 0.2604 | 6 | 144,329,726 | 0.0083 | HYMAI | 3674 | Promoters |
